In Brief: "Mad cow" disease
This article was originally published in The Rose Sheet
Executive Summary
"Mad cow" disease: FDA Office of Cosmetics and Colors "refining" recommendations on use of bovine-derived ingredients in cosmetics to be more "scientifically relevant" to the risk of bovine spongiform encephalopathy transmission, the agency said. FDA sent letters to CTFA and ICMAD May 20, urging cosmetics companies not to use material derived from bovine tissue in their products ("The Rose Sheet" Sept. 2, 1996, p. 2). In a July 19 response, CTFA suggested the agency adopt the World Health Organization's standards on avoiding BSE-infected bovine materials as an alternative to its more inclusive proposition. In a Jan. 3 Federal Register notice, FDA issued a proposed rule banning animal protein derived from ruminant and mink tissues in animal feed. The proposal does not apply to raw materials...
"Mad cow" disease: FDA Office of Cosmetics and Colors "refining" recommendations on use of bovine-derived ingredients in cosmetics to be more "scientifically relevant" to the risk of bovine spongiform encephalopathy transmission, the agency said. FDA sent letters to CTFA and ICMAD May 20, urging cosmetics companies not to use material derived from bovine tissue in their products ("The Rose Sheet" Sept. 2, 1996, p. 2). In a July 19 response, CTFA suggested the agency adopt the World Health Organization's standards on avoiding BSE-infected bovine materials as an alternative to its more inclusive proposition. In a Jan. 3 Federal Register notice, FDA issued a proposed rule banning animal protein derived from ruminant and mink tissues in animal feed. The proposal does not apply to raw materials.... |